WAVE Life Sciences (WVE) Misses Q1 EPS by 3c

WAVE Life Sciences (NASDAQ: WVE) reported Q1 EPS of ($0.24), $0.03 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $12.54 million versus the consensus estimate of $25 million.

For earnings history and earnings-related data on WAVE Life Sciences (WVE) click here.

You May Also Be Interested In

• Stitch Fix (SFIX) Tops Q4 EPS by 4c; Offers Guidance
• Cracker Barrel (CBRL) Tops Q4 EPS by 89c, Offers Guidance
• Wave Life Sciences Initiates Phase 2a Combination Trial of WVE-007 (GalNAc-siRNA) with Tirzepatide for Obesity